Skip to main content
Log in

The role of Dextran on the blood level of35S-Calcium Dobesilate in humans

  • Short Communication
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The concomitant administration of Dextran and Calcium Dobesilate might be foreseen in clinical practice since the former is used as a blood volume restorer, and the latter as a protector of the capillary blood vessel walls. The aim of this study is to investigate if the intravenous administration of Dextran is liable to influence the pharmacokinetics of orally administrated 35S Calcium Dobesilate. The maximum blood level values in the group treated simultaneously with Calcium Dobesilate and Dextran were similar to those obtained after the administration of Calcium Dobesilate alone. The rate of protein binding was practically identical in both Dextran-treated groups, whether Calcium Dobesilate was given before or after Dextran. This experiment showed that Dextran does not affect the blood level of Calcium Dobesilate in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Esteve, A., Laporte, J., Rodriguez, L., Demestre, I., December 1968, Étude pharmacodynamique du dobésilate de calcium. Spanish Society for Physiological Science, Madrid.

  2. Sevin, R., Cuendet, J. F., 1969, Calcium dobesilate in diabetic retinopathy. Ophthalmologica,159, 126–135.

    Article  CAS  PubMed  Google Scholar 

  3. Berson, I., 1970, A propos d’un nouveau veinotrope de synthèse. Praxis,59, 1305–1306.

    CAS  PubMed  Google Scholar 

  4. Sevin, R., 1970, Treatments for diabetic retinopathy. Advances in Ophthalmology,24, 315–375.

    Google Scholar 

  5. Berson, I., 1972, Un nouveau veinotrope de synthèse en proctologie. Praxis,61, 52–54.

    CAS  PubMed  Google Scholar 

  6. Sevin, R., Cuendet, J. F., 1971, The action of calcium dobesilate on capillary permeability in diabetics. Ophthalmologica,82, 33–40.

    Article  Google Scholar 

  7. Benakis, A., Millot, A., Plessas, Ch., Glasson, B., 1971, Localisation, distribution, elimination et metabolisme du dihydroxy-2,5 benzène sulfonate de calcium (dobésilate de calcium) marqué au35S chez la souris, le rat et le lapin. XIe congrès international de Thérapeutique, Barcelone.

  8. Benakis, A., Glasson, B., Bouvier, C. A., Ritschard, J., Krahenbuhl, B., Jung, A., Hachen, H. J., 1974, Métabolisme et pharmacocinetique du dobésilate de calcium chez l’homme. Thérapie,29, 415–427.

    Google Scholar 

  9. Laporte, J., Castillo, R., 1968, Antagonizacion de los efectos del dextrano sobre el tiempo de sangria medio del conejo. 9th National Congress of the Spanish Society for Physiological Science, Madrid.

  10. Thomas, J., Dorme, N., Sergant, M., Raynaud, G., Bouvet, P., 1972, Action du dobesilate de calcium sur la résistance et la permeability capillaires et sur le temps de saignement et l’adhésivité plaquettaire modifiés par le dextran. Annales pharmaceutiques Francaises,30, 415–427.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plessas, C.T., Varonos, D., Plessas, S.T. et al. The role of Dextran on the blood level of35S-Calcium Dobesilate in humans. European Journal of Drug Metabolism and Pharmacokinetics 1, 125–127 (1976). https://doi.org/10.1007/BF03189266

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189266

Key-words

Navigation